CORECARD CORP (CCRD) Fundamental Analysis & Valuation

NYSE:CCRD • US45816D1000

23.6 USD
-0.72 (-2.96%)
At close: Oct 30, 2025
23.5 USD
-0.1 (-0.42%)
After Hours: 10/30/2025, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CCRD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall CCRD gets a fundamental rating of 6 out of 10. We evaluated CCRD against 277 industry peers in the Software industry. CCRD has an excellent financial health rating, but there are some minor concerns on its profitability. CCRD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. CCRD Profitability Analysis

1.1 Basic Checks

  • CCRD had positive earnings in the past year.
  • CCRD had a positive operating cash flow in the past year.
  • In the past 5 years CCRD has always been profitable.
  • CCRD had a positive operating cash flow in each of the past 5 years.
CCRD Yearly Net Income VS EBIT VS OCF VS FCFCCRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.30%, CCRD belongs to the top of the industry, outperforming 88.07% of the companies in the same industry.
  • CCRD has a better Return On Equity (14.23%) than 81.75% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.25%, CCRD belongs to the best of the industry, outperforming 90.18% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CCRD is above the industry average of 10.89%.
Industry RankSector Rank
ROA 11.3%
ROE 14.23%
ROIC 13.25%
ROA(3y)12%
ROA(5y)13.17%
ROE(3y)14.43%
ROE(5y)16.48%
ROIC(3y)15.06%
ROIC(5y)16.56%
CCRD Yearly ROA, ROE, ROICCCRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • With a decent Profit Margin value of 12.36%, CCRD is doing good in the industry, outperforming 73.68% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CCRD has declined.
  • With an excellent Operating Margin value of 15.96%, CCRD belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CCRD has declined.
  • CCRD has a Gross Margin of 45.41%. This is in the lower half of the industry: CCRD underperforms 70.18% of its industry peers.
  • CCRD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.96%
PM (TTM) 12.36%
GM 45.41%
OM growth 3Y-20.51%
OM growth 5Y-20.84%
PM growth 3Y-20.28%
PM growth 5Y-21.57%
GM growth 3Y-10.43%
GM growth 5Y-10.05%
CCRD Yearly Profit, Operating, Gross MarginsCCRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. CCRD Health Analysis

2.1 Basic Checks

  • CCRD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CCRD has less shares outstanding than it did 1 year ago.
  • CCRD has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CCRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCRD Yearly Shares OutstandingCCRD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CCRD Yearly Total Debt VS Total AssetsCCRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 10.83 indicates that CCRD is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 10.83, CCRD belongs to the best of the industry, outperforming 87.37% of the companies in the same industry.
  • There is no outstanding debt for CCRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.83
ROIC/WACC1.21
WACC10.99%
CCRD Yearly LT Debt VS Equity VS FCFCCRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • CCRD has a Current Ratio of 4.29. This indicates that CCRD is financially healthy and has no problem in meeting its short term obligations.
  • CCRD has a Current ratio of 4.29. This is amongst the best in the industry. CCRD outperforms 85.26% of its industry peers.
  • A Quick Ratio of 4.29 indicates that CCRD has no problem at all paying its short term obligations.
  • CCRD has a better Quick ratio (4.29) than 85.26% of its industry peers.
Industry RankSector Rank
Current Ratio 4.29
Quick Ratio 4.29
CCRD Yearly Current Assets VS Current LiabilitesCCRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CCRD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 216.22% over the past year.
  • CCRD shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.33% yearly.
  • CCRD shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.61%.
  • The Revenue has been growing by 10.85% on average over the past years. This is quite good.
EPS 1Y (TTM)216.22%
EPS 3Y-8.08%
EPS 5Y-11.33%
EPS Q2Q%106.67%
Revenue 1Y (TTM)23.61%
Revenue growth 3Y5.96%
Revenue growth 5Y10.85%
Sales Q2Q%27.52%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40.25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCRD Yearly Revenue VS EstimatesCCRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CCRD Yearly EPS VS EstimatesCCRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. CCRD Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.17, the valuation of CCRD can be described as rather expensive.
  • 75.09% of the companies in the same industry are more expensive than CCRD, based on the Price/Earnings ratio.
  • CCRD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.71.
  • A Price/Forward Earnings ratio of 21.03 indicates a rather expensive valuation of CCRD.
  • CCRD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CCRD is cheaper than 70.88% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.82. CCRD is around the same levels.
Industry RankSector Rank
PE 20.17
Fwd PE 21.03
CCRD Price Earnings VS Forward Price EarningsCCRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 88.42% of the companies in the same industry are more expensive than CCRD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CCRD is valued a bit cheaper than 79.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.62
EV/EBITDA 10.75
CCRD Per share dataCCRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • CCRD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CCRD may justify a higher PE ratio.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CCRD Dividend Analysis

5.1 Amount

  • CCRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CCRD Fundamentals: All Metrics, Ratios and Statistics

CORECARD CORP

NYSE:CCRD (10/30/2025, 8:04:00 PM)

After market: 23.5 -0.1 (-0.42%)

23.6

-0.72 (-2.96%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-30
Earnings (Next)02-18
Inst Owners44.04%
Inst Owner ChangeN/A
Ins Owners29.03%
Ins Owner Change-161.9%
Market Cap183.84M
Revenue(TTM)64.81M
Net Income(TTM)8.01M
Analysts43.33
Price Target21.42 (-9.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.07%
Min EPS beat(2)12.56%
Max EPS beat(2)71.57%
EPS beat(4)4
Avg EPS beat(4)90.54%
Min EPS beat(4)12.56%
Max EPS beat(4)205.01%
EPS beat(8)7
Avg EPS beat(8)147.98%
EPS beat(12)10
Avg EPS beat(12)104.9%
EPS beat(16)13
Avg EPS beat(16)90.04%
Revenue beat(2)2
Avg Revenue beat(2)8.46%
Min Revenue beat(2)4.86%
Max Revenue beat(2)12.06%
Revenue beat(4)4
Avg Revenue beat(4)10.95%
Min Revenue beat(4)4.86%
Max Revenue beat(4)18.42%
Revenue beat(8)6
Avg Revenue beat(8)6.08%
Revenue beat(12)9
Avg Revenue beat(12)5.64%
Revenue beat(16)13
Avg Revenue beat(16)10.03%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.17
Fwd PE 21.03
P/S 2.84
P/FCF 20.62
P/OCF 12.97
P/B 3.26
P/tB 3.26
EV/EBITDA 10.75
EPS(TTM)1.17
EY4.96%
EPS(NY)1.12
Fwd EY4.75%
FCF(TTM)1.14
FCFY4.85%
OCF(TTM)1.82
OCFY7.71%
SpS8.32
BVpS7.23
TBVpS7.23
PEG (NY)0.5
PEG (5Y)N/A
Graham Number13.8
Profitability
Industry RankSector Rank
ROA 11.3%
ROE 14.23%
ROCE 17.17%
ROIC 13.25%
ROICexc 28.53%
ROICexgc 28.53%
OM 15.96%
PM (TTM) 12.36%
GM 45.41%
FCFM 13.76%
ROA(3y)12%
ROA(5y)13.17%
ROE(3y)14.43%
ROE(5y)16.48%
ROIC(3y)15.06%
ROIC(5y)16.56%
ROICexc(3y)29.29%
ROICexc(5y)46.89%
ROICexgc(3y)29.39%
ROICexgc(5y)46.95%
ROCE(3y)19.51%
ROCE(5y)21.44%
ROICexgc growth 3Y-28.07%
ROICexgc growth 5Y-26.9%
ROICexc growth 3Y-28.07%
ROICexc growth 5Y-26.9%
OM growth 3Y-20.51%
OM growth 5Y-20.84%
PM growth 3Y-20.28%
PM growth 5Y-21.57%
GM growth 3Y-10.43%
GM growth 5Y-10.05%
F-Score8
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 162.65%
Cap/Sales 8.12%
Interest Coverage 250
Cash Conversion 104.4%
Profit Quality 111.28%
Current Ratio 4.29
Quick Ratio 4.29
Altman-Z 10.83
F-Score8
WACC10.99%
ROIC/WACC1.21
Cap/Depr(3y)124.94%
Cap/Depr(5y)169.94%
Cap/Sales(3y)10.15%
Cap/Sales(5y)12.34%
Profit Quality(3y)121.7%
Profit Quality(5y)114.39%
High Growth Momentum
Growth
EPS 1Y (TTM)216.22%
EPS 3Y-8.08%
EPS 5Y-11.33%
EPS Q2Q%106.67%
EPS Next Y40.25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.61%
Revenue growth 3Y5.96%
Revenue growth 5Y10.85%
Sales Q2Q%27.52%
Revenue Next Year17.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y316.93%
EBIT growth 3Y-15.78%
EBIT growth 5Y-12.25%
EBIT Next Year200.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.39%
FCF growth 3Y-33.89%
FCF growth 5Y-36.88%
OCF growth 1Y-39.98%
OCF growth 3Y-13.36%
OCF growth 5Y-11.34%

CORECARD CORP / CCRD FAQ

What is the fundamental rating for CCRD stock?

ChartMill assigns a fundamental rating of 6 / 10 to CCRD.


What is the valuation status for CCRD stock?

ChartMill assigns a valuation rating of 6 / 10 to CORECARD CORP (CCRD). This can be considered as Fairly Valued.


What is the profitability of CCRD stock?

CORECARD CORP (CCRD) has a profitability rating of 6 / 10.


What is the financial health of CORECARD CORP (CCRD) stock?

The financial health rating of CORECARD CORP (CCRD) is 10 / 10.


What is the earnings growth outlook for CORECARD CORP?

The Earnings per Share (EPS) of CORECARD CORP (CCRD) is expected to grow by 40.25% in the next year.